Osteoclast Fusion: Physiological Regulation of Multinucleation through Heterogeneity—Potential Implications for Drug Sensitivity
Classically, osteoclast fusion consists of four basic steps: (1) attraction/migration, (2) recognition, (3) cell–cell adhesion, and (4) membrane fusion. In theory, this sounds like a straightforward simple linear process. However, it is not. Osteoclast fusion has to take place in a well-coordinated...
Main Author: | Kent Søe |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-10-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/21/20/7717 |
Similar Items
-
Cell-cell fusion: human multinucleated osteoclasts
by: Zeng Zhi-Yong, et al.
Published: (2009-12-01) -
Osteoclast Multinucleation: Review of Current Literature
by: Joe Kodama, et al.
Published: (2020-08-01) -
Fusion Potential of Human Osteoclasts In Vitro Reflects Age, Menopause, and In Vivo Bone Resorption Levels of Their Donors—A Possible Involvement of DC-STAMP
by: Anaïs M. J. Møller, et al.
Published: (2020-09-01) -
Letrozole Suppresses the Fusion of Osteoclast Precursors through Inhibition of p38-Mediated DC-STAMP Pathway
by: Hyung Joon Kim, et al.
Published: (2020-11-01) -
BCPA {<i>N</i>,<i>N</i>′-1,4-Butanediylbis[3-(2-chlorophenyl)acrylamide]} Inhibits Osteoclast Differentiation through Increased Retention of Peptidyl-Prolyl <i>cis-trans</i> Isomerase Never in Mitosis A-Interacting 1
by: Eugene Cho, et al.
Published: (2018-11-01)